Big pharma pushes back against WHO patent pool

The leaders of some of the world’s largest pharma companies appear to be resistant to a World Health Organization (WHO) voluntary pool aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Has the public got the taste for free medicine?

5 June 2020 The COVID-19 pandemic has seen the fundamental principles of the IP system called into question. How can we go on as before?

Americas

BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling

9 June 2020 Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

Big Pharma

EC backs voluntary COVID-19 vaccine licensing

18 June 2020 The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.

More on this story

Big Pharma

Has the public got the taste for free medicine?

5 June 2020 The COVID-19 pandemic has seen the fundamental principles of the IP system called into question. How can we go on as before?

Americas

BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling

9 June 2020 Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

Big Pharma

EC backs voluntary COVID-19 vaccine licensing

18 June 2020 The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.

More on this story

Big Pharma

Has the public got the taste for free medicine?

5 June 2020 The COVID-19 pandemic has seen the fundamental principles of the IP system called into question. How can we go on as before?

Americas

BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling

9 June 2020 Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

Big Pharma

EC backs voluntary COVID-19 vaccine licensing

18 June 2020 The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.